Product Information
INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL is a generic product labeled by Novo Nordisk, priced at $6.9545 per ML under NDC 73070020011. Its NADAC has been published 333 times since May 20, 2020.
Strength
100 [iU]/mL
Manufacturer
Novo NordiskNDC
73070020011
Classification
Generic
Dosage Form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Effective Date
5/20/2026
Active Ingredients
INSULIN ASPARTApproval Type
Biologic (BLA)
FDA Application
BLA021172On Market Since
11/1/2001
Pharmacological Classes
Price Statistics
The NADAC for INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL has been published 333 times since May 20, 2020, and over the history we have for it it has declined 51.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.9545 per ML |
|---|---|
| All-time high | $14.5662 (Nov 16, 2022) |
| All-time low | $6.9294 (Jan 21, 2026) |
| 52-week high | $6.9567 |
| 52-week low | $6.9294 |
| Median price | $14.3668 |
| Average price | $11.2216 |
| Largest weekly change | -51.8% (Jan 10, 2024) |
| Weeks tracked | 333 |
| Tracking since | May 20, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novo Nordisk manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
insulin aspart market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Insulin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL?
The current National Average Drug Acquisition Cost (NADAC) for INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL, manufactured by Novo Nordisk, is $6.9545 per ML (NDC 73070020011), effective Sep 30, 2026.
How has the price of INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL changed over time?
Over the history we have for it, the NADAC for INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL has declined 51.9%. It has been tracked across 333 weekly CMS publications since May 20, 2020.
What are the highest and lowest recorded NADAC prices for INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL?
Since May 20, 2020, the NADAC for INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL has ranged from a low of $6.9294 (Jan 21, 2026) to a high of $14.5662 (Nov 16, 2022), with a median of $14.3668 per ML.
Are there cheaper alternatives to INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NOVOLOG MIX 70-30 VIAL, is $6.9287 per ML — about 0% below INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL.
Who manufactures INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL?
INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL (NDC 73070020011) is labeled by Novo Nordisk, and CMS classifies it as a generic product.